Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by HeartBeam, Inc.

< Previous 1 2 Next >
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Reports Fourth Quarter and Full Year 2024 Results
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Reports Third Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Reports Second Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Added to Russell Microcap® Index
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Reports First Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
From HeartBeam, Inc.
Via Business Wire
Tickers BEAT
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.